Amoxicillin/Clavulanic acid Siromed

Medicinal product

(Invented) name

Amoxicillin/Clavulanic acid Siromed

Active substance (s)

Amoksicilinas/Klavulano rūgštis

Strength

875 mg/125 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR02, Amoxicillin and beta-lactamase inhibitor

Marketing authorisation holder

UAB NVT, Lietuva

Date of authorisation

2019-03-07

Date of renewal

2023-10-10

Documents

4346 pakuotes lapelis_2023-10-10.docx

Amoxicillin_Clavulan acid_Siromed_viesas_AR .pdf

4346 Amoxic_Cl ac_Siromed_perr2023-10-10.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Amoksicilinas	875 mg
Klavulano rūgštis	125 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
101091	87202	1087202	lizdinė plokštelė	N14		Receptinis	LT/1/19/4346/001	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-10-10	Perregistruotas
2019-03-07	Registruotas